KERPA Partners with Handtevy to Bring State-of-the-Art Lifesaving Technology to the Children of the Kootenays, British Columbia


Handtevy, the leader in pediatric emergency technology, has partnered with KERPA (Kootenay Emergency Response Physicians Association) program to provide their groundbreaking Handtevy Pediatric Resuscitation System to all Emergency Medical Services (EMS) physicians in the program.”

In pediatric emergency situations, every second counts, so after passing rigorous testing and evaluation, KERPA chose Handtevy’s flagship solution, Handtevy Mobile, as their go-to, frontline, lifesaving tool.

“The Kootenay Region is largely a rural and remote wilderness. We send a licensed physician who must deliver extensive lifesaving care in the field due to response and transportation times. Handtevy Mobile gives us the ability to access complex medication doses, in seconds, when it matters most.” – Dr. Nicholas Sparrow MBBS, BSC, CCFP-EM, an ED & EMS Physician, and the President of KERPA

Handtevy Mobile’s breakthrough technology allows EMS and other emergency healthcare professionals to obtain accurate medication dosing for pediatric emergencies rapidly, at the point of care. The medications and equipment listed in Handtevy Mobile are customized to KERPA’s unique formulary, a feature that will reduce errors and ultimately save children and adult lives across the region.

Handtevy Mobile will be deployed on phones and tablets throughout KERPA to ensure the highest level of pediatric emergency care at the highest levels of excellence in the field.

“We’re proud to team up with KERPA and their vital mission to serve the residents of the Kootenay’s. KERPA physicians must take all the best tools with them to rugged environments and Handtevy puts a suite of lifesaving solutions in the palm of their hands.” – Dr. Peter Antevy, M.D., Founder and Chief Medical Officer of Handtevy.

In order to get the most out of the state-of-the-art system and the latest in lifesaving techniques, the rollout will be paired with Handtevy’s nationally acclaimed instructor course that will allow KERPA to onboard new physicians quickly.

Included with Handtevy Mobile is “CPR Assist,” an app feature that leads high-performance EMS teams through the highly regimented CPR bundle. Using the auditory and visual cues provided by the app, clinicians accurately maintain compression and ventilation rates, defibrillate as needed, and administer accurate medications and equipment, all while documenting the event in real time. It’s a unique feature that brings calm to the chaos of an out-of-hospital cardiac arrest for both children and adults.

Handtevy was founded by Dr. Peter Antevy, a nationally recognized expert in the field of pre-hospital pediatrics. His passion for solving this complex issue stemmed from a medication error he made early in his career that led him to drastically impact currently accepted practice. He is a Pediatric Emergency Medicine Physician at Joe DiMaggio Children’s Hospital and also serves as the EMS Medical Director for Davie Fire-Rescue, Coral Springs Fire Department, Southwest Ranches Fire Rescue and American Ambulance. Dr. Antevy is also the Associate Medical Director for Palm Beach County Fire Rescue and serves as the President of the Greater Broward EMS Medical Directors’ Association, an organization whose providers serve the 1.5 million residents of Broward County, Florida. For his efforts, Dr. Antevy was awarded the prestigious Raymond H. Alexander EMS Medical Director of the Year Award in 2014 and in 2018 he was named the National EMS Medical Director of the Year by the NAEMT. He also was honored as one of the 2015 Top Ten Innovators in EMS by Journal of Emergency Medical Services (JEMS).

For more information on the Handtevy System contact info@handtevy.com or visit the Handtevy website

Share article on social media or email:

The National Children’s Cancer Society Receives $25,000 Grant from The American Legion Child Welfare Foundation


News Image

“With help from this grant, we will be able to reach more families in need of our assistance,” said NCCS President and CEO Mark Stolze.

The American Legion Child Welfare Foundation (CWF) awarded The National Children’s Cancer Society (NCCS) $25,000. The grant will help fund NCCS’s Transportation Assistance Fund.

Each year, nearly 16,000 children are diagnosed with cancer. When faced with this news, the NCCS believes a family should be focused on one thing—getting their child well again. Yet, many struggle with the financial consequences of a cancer diagnosis and are unable to meet basic needs like getting their child to and from treatment. The Transportation Assistance Fund alleviates the financial burden of travel and lodging for families seeking care.

The CWF is focused on contributing to the physical, mental, emotional and spiritual welfare of children. The new grant will help raise awareness of the NCCS program so that more children with cancer receive the lifesaving care they need.

The NCCS partners with nearly 200 childhood cancer treatment centers across the country. The grant will fund the creation and production of informational materials on the support provided by the organization so these facilities can provide them to families in need. Additionally, the NCCS estimates the grant will provide transportation assistance to approximately 70 new families, a 20% increase.

“We are thrilled to receive this grant. These funds will help inform families battling childhood cancer of the services provided by the NCCS. It comes at a critical time. In the midst of an ongoing pandemic, travel is increasingly expensive and challenging, especially for a sick child. With help from this grant, we will be able to reach more families in need of our assistance,” said NCCS President and CEO Mark Stolze.

The NCCS is committed to being there for children battling childhood cancer—NO MATTER WHAT. Programs like the Transportation Assistance Fund provide vital resources to ease the financial and emotional burdens families experience when they have a child with cancer.

The NCCS looks forward to helping even more kids get on the road to survival thanks to the grant from the CWF.

The National Children’s Cancer Society (NCCS), headquartered in St. Louis, Mo., is a not-for-profit organization providing support to families making their way through the daunting world of childhood cancer and survivorship. With over 30 years of experience serving more than 46,000 children, the NCCS is able to take a “no matter what” approach to help families stay strong, stay positive and stay together. The NCCS has been recognized as a Better Business Bureau Accredited Charity and earned a GuideStar Platinum Seal of Transparency. For more information, call 314-241-1600, visit theNCCS.org or follow on Facebook, Twitter and Instagram.

Share article on social media or email:



Convectium, Leader in Cannabis Industry Automation, Takes Revenue-Based Funding From Decathlon Capital Partners To Support Growth


“A seasoned management team that combines experience in the cannabis industry with extensive background in finance and operations positions Convectium to maintain its industry leadership.” – Chris Risey, VP, Decathlon Capital

The parent corporation of Convectium, a leader in automated filling equipment for the cannabis industry, has landed a significant investment from Decathlon Capital Partners to support its further expansion. Jacksam Corporation (OTCMKTS: JKSM), which does business as Convectium, has successfully closed on a revenue-based financing package with Decathlon Capital Partners to help fund its continued growth.

The investment package will be used by Convectium to support sales expansion, enhanced customer service and a wider range of product offerings. The company is headquartered at Newport Beach, Calif. Convectium, established in 2014, provides automated solutions that address filling and capping of vape cartridges and pods and well as pre-rolling of joints.

“As the legalized recreational cannabis market expands into a growing number of states, including New York, producers of cannabis and CBD products turn to Convectium for automated technology that eliminates labor-intensive processes,” said Mark Adams, chief executive officer of Convectium. “Our products deliver immediately quantifiable return on investment while adding the precision, speed and effectiveness that improve the quality of cannabis and CBD products.”

Chris Risey, vice president of Decathlon Capital Partners, said Convectium’s patent-pending technology and multi-national strategic partnerships establish a solid base for further market expansion as well as development of new opportunities in large states such as New York, Massachusetts and California.

“A seasoned management team that combines experience in the cannabis industry with extensive background in finance and operations positions Convectium to maintain its industry leadership,”Risey said. Because the investment is a revenue-based finance arrangement, Jacksam did not exchange any equity or ownership for growth capital. Instead, the investment will be repaid through the company’s future revenue.

About Jacksam Corporation

Jacksam Corporation, doing business as Convectium, designs and markets automated vape, POD and cartridge filling and capping equipment for the cannabis and CBD industry. Convectium is also a distributor of other CBD and Cannabis automation solutions including the “PreRoll-ER” automated pre-roll machine. Its automated equipment is designed and built in the U.S. and carries full UL certification in the U.S. Using its automated equipment, Convectium’s customers can increase their output by up to 60 times over hand filling. Convectium is focused on helping its customers automate their workflow and quickly get custom branded products onto dispensary shelves. Over 250 companies, including many dominant brands and multi state operators (MSOs) in the space, rely on Convectium for automation of their production and back-office operations. For more information, visit https://www.convectium.com.

About Decathlon Capital Partners

Decathlon Capital Partners provides growth capital for companies seeking alternatives to traditional equity investment. Through the use of highly customized revenue-based financing solutions, Decathlon provides long-term growth capital without the dilution, loss of control and operational overhead that often comes with equity-based funding. With offices in Palo Alto and Park City, Decathlon is the largest revenue-based funding investor in the U.S. and is active across a wide range of sectors. Learn more at https://www.decathloncapital.com.

Share article on social media or email:

Researchers from Prairie Health discover novel method of subtyping depression


Bar chart with 10 symptoms on the x axis plotted against symptom likelihood, with 5 bars for the 5 subtypes plotted on each symptom. One subtype has a clear highest likelihood for each symptom.

This graph shows the likelihood of each symptom of depression appearing in each of the five subtypes identified.

The team led by Prairie Health researchers applied natural language processing techniques and machine learning algorithms to a massive repository of psychiatric notes. The result of this novel approach was the discovery of 5 clinically-relevant subtypes of depression.

Affecting more than 264 million people every year, depression is a leading cause of disability worldwide. A key characteristic of depression is just how different symptoms can manifest for different people, both in severity of symptoms and type of symptoms experienced. For example, one person may experience hopelessness and insomnia, while another may experience low motivation and difficulty concentrating. A doctor might diagnose both as having depression.

The differences are rarely as distinct as that between individuals, but it’s these differences that lead to challenges both during treatment and progress tracking. There are accepted tools to measure depression with its subtypes like the Patient Health Questionnaire-9 (PHQ-9), but these inputs aren’t consistently tracked and don’t capture the full range of symptoms in a disease as heterogeneous a disorder as depression.

There is, however, a rich, untapped resource that describes depression symptoms in great detail: clinician notes. During most visits with patients in the medical setting, mental health providers like psychiatrists record notes from patients’ appointments, describing changes in appearance, mood, affect, emotions and more. While much more descriptive than questionnaires like the PHQ-9, the challenge is parsing and comparing notes from one doctor to another and analyzing these records across a population.

That’s where researchers at Prairie Health, a mental health technology company, come in, developing a novel technique to extract information from clinician notes, in a new paper in Nature Scientific Reports.

In partnership with the United Kingdom’s National Health Service (NHS), the team applied natural language processing techniques and machine learning algorithms to a massive repository of psychiatric notes from medical centers in the UK. The result of this novel approach was the discovery of 5 clinically-relevant subtypes of depression.

Benson Kung, lead author for the study and co-founder of Prairie Health, emphasized the importance of the type of data used for this analysis. “It is one thing to develop the machine learning methods but it is critical to have access to longitudinal, comprehensive clinical data like what’s found in NHS’s records. This allows us to learn about the patient from what their care providers are saying in free text rather than always relying on questionnaires.”

What makes these subtypes especially important is their clinical relevance. The researchers found that these additional characterizations were predictive of the future course of illness. This means clinics and health plan managers could more easily identify depressed individuals who could benefit from specific interventions suited to that subtype. When coupled with other sources of information, such as formal symptom assessment, this strategy holds promise of making treatment plans more personalized and effective, as compared to the one-size-fits-all approach to the treatment of what is a heterogeneous disease.

“The beauty of this study is that it uses automated techniques that could be widely implemented, allowing for future analyses in more varied populations and settings” commented Maurice Chiang, CEO. “Prairie’s vision is to use data to rapidly find the best treatment possible for an individual in order to minimize the suffering and disability associated with mental illness.”

Read the full paper here: https://www.nature.com/articles/s41598-021-01954-4

About Prairie Health

Prairie Health is a technology company on a mission to reduce all barriers to mental healthcare and modernize treatment, achieved by creating measurement-based and data-driven tools that improve access and outcomes. Prairie helps people with conditions like depression and anxiety get the best possible care by offering convenient appointments with top mental health providers, genetic testing to guide treatment choice, medication delivery, care coordination, and personalized outcomes tracking.

Share article on social media or email:

Joseph Simone, President of Simone Development Companies, Sees Google Searches as Important Guide for Healthcare Real Estate Development


Joe Simone

“Developers must understand that the words ‘near me’ are the gold standard. We must respond to that search term by locating our projects as close to consumers and neighborhoods as possible,” said Joe Simone.

Consumers’ increasing use of Google’s search engine to locate medical care should help guide healthcare real estate developers’ site planning, said Joseph Simone of Simone Development Companies.

“The phrase ‘urgent care near me’ is one of the top terms, with almost 2 million searches each month,” said Joseph Simone, President of Simone Development Companies. “Other top searches are ‘hospital near me’ and ‘walk-in clinic near me.’ These terms underscore the importance of web analytics when real estate developers consider their site selection and what kind of tenant mix developers must acquire.”

Informed use of search engine analytics can help developers determine which communities most often search for urgent care or specialties, thereby improving the chances of immediate success for a new care facility.

“Anyone on Google who is searching for a service wants that service nearby, which is why we have seen the proliferation of urgent care in non-traditional medical locations like shopping centers,” said Joe Simone. “Now we see outpatient surgical centers and other medical services migrate to malls as proximity to consumers becomes increasingly critical.”

Simone Development Companies has been a pioneer in using analytics and market data to bring healthcare where consumers want it—in their neighborhoods.

Simone’s Boyce Thompson Center in Yonkers, N.Y. includes outpatient care, physician offices, a pharmacy, a med spa, retail and restaurants. Similarly, the Purchase Professional Park in Purchase, N.Y. combines first-class office and medical space, exceptional amenities and one of the most convenient office locations in the region.

“Developers must understand that the words ‘near me’ are the gold standard. We must respond to that search term by locating our projects as close to consumers and neighborhoods as possible,” said Joe Simone.

Simone Development Companies is a fully integrated private real estate investment and development company that acquires and develops healthcare, mixed-use, commercial, industrial, retail and residential properties. Headquartered at the Hutchinson Metro Center, it boasts a portfolio of over seven million square feet throughout the Bronx, Manhattan, Queens, Long Island, Westchester, Orange and Fairfield Counties and New Jersey. With services spanning acquisition, development, construction, finance, asset management, accounting, leasing and property management, Simone Development Companies is set apart by its creatively oriented management team, long-term asset ownership and its pursuit of visionary development.

Share article on social media or email:

Chicago Divorce Law Firm Welcomes New Family Law Attorney


Associate Attorney Kassandra Morfin joins The Law Office of George J. Skuros.

Attorney Morfin believes in approaching all legal matters with a focus on transparency, reliability, and teamwork. Ms. Morfin’s work ethic, versatility, and multilingual capabilities make her an invaluable resource to the firm.

The Law Office of George J. Skuros, a Chicago family and divorce law firm, is excited to welcome Associate Attorney Kassandra R. Morfin to their legal team. Attorney Morfin believes in approaching all legal matters with a focus on transparency, reliability, and teamwork. Ms. Morfin’s work ethic, versatility, and multilingual capabilities make her an invaluable resource to the firm.

Attorney Morfin is adept at handling a multitude of legal issues ranging from family law to estate planning and real estate transactions. She can proficiently tackle cases involving premarital and postmarital agreements, child support, domestic violence matters, disposition of assets, spousal maintenance, and parentage. Ms. Morfin also skillfully applies her legal knowledge to cases involving probate matters that involve decedents’ estates and guardianship for disabled adults or minors.

Kassandra Morfin is committed to the legal community, holding membership across several professional organizations, including the Chicago Bar Association, the Illinois State Bar Association, and the Hispanic Lawyers Association of Illinois.

Before graduating with her Juris Doctor degree from UIC John Marshall Law School in Chicago, Attorney Morfin dedicated a vast amount of her time to her collegiate community. While at law school, Ms. Morfin served as president of the First Generation Law Student Association — an organization that she founded. She also served as president for the Children and Family Law Society and was actively involved in the law school’s Family Law and Domestic Violence Legal Clinic. Prior to attending law school, she completed an internship with the Domestic Violence Legal Clinic at the Harrison Street Courthouse.

About the Law Office of George J. Skuros

Attorney George J. Skuros founded his law firm in 1984 with a focus on family law and divorce cases. Since 1984, the firm has expanded to two offices and is available to serve clients throughout the city of Chicago. Dedicated to helping families through some of the most challenging times of their lives, The Law Office of George J. Skuros extends its services to the residents of Cook County, DuPage County, Kane County, Lake County, and Will County.

Equipped with over three decades of legal experience, the firm prioritizes client relationships and makes an effort to keep their clients thoroughly informed. No matter the size of the case, each matter is personally addressed by Mr. Skuros or Ms. Morfin. The Law Office of George J. Skuros provides legal guidance for multiple types of complex family issues, including asset dissipation, property valuation, paternity determination, orders of protection, child support, and the creation of parenting plans.

For more information or to schedule a free consultation, call 312-884-1222. To learn more about The Law Office of George J. Skuros, visit https://www.skuroslaw.com/.

Share article on social media or email:

Good Engineering Practice (Second Edition)


ISPE  Good  Practice Guide:  Good  Engineering  Practice  (Second Edition)

ISPE Good Practice Guide: Good Engineering Practice (Second Edition)

“This Guide considers the entire range of pharmaceutical engineering activity and identifies key attributes of GEP within it, including how GEP relates to and interfaces with GxP,” said Guide Co-Lead Joerg Block, Ph.D., GMP Compliance Engineer, Bayer AG PH-PS Engineering.

The International Society for Pharmaceutical Engineering (ISPE) announces the release of its latest Guide in November 2021, ISPE Good Practice Guide: Good Engineering Practice (Second Edition).

The ISPE Good Practice Guide: Good Engineering Practice (Second Edition) defines the practices and processes under Good Engineering Practice (GEP) that support and enable the design, delivery, and operation of engineered systems. The scope of GEP covers the complete lifecycle of engineering projects and engineered systems from conceptual design to retirement. This Guide considers the entire range of pharmaceutical engineering activity and identifies key attributes of GEP within it, including how GEP relates to and interfaces with GxP.

Updates for the second edition include alignment with current industry practice, particularly with respect to the ISPE Baseline® Guide: Commissioning and Qualification (Second Edition) which incorporates ASTM E2500, EU GMP Annex 15, ICH Q8, Q9, and Q10, and applicable regulatory guidance. This Good Practice Guide incorporates the concepts and application of Quality Risk Management (QRM), specifically the application of GEP as an enabler for QRM-based integrated Commissioning and Qualification (C&Q).

“Running a business efficiently requires working practices that will deliver optimum value for a given scope of work,” said Guide Co-Lead Chip Bennett, Associate Director, Global C&Q, CAI. “The adoption of GEP can lead to a balance of expenditure and activity in relation to benefits. The benefit is most likely gained when finite resources are focused on identified higher-risk aspects or when high-risk aspects are more intensely controlled to enable reliable delivery and seamless production. Specific potential benefits include facilitation of speed-to-market of regulated products through efficient delivery of manufacturing facilities and systems and an optimized level of quality oversight, commensurate with the maturity of established GEP.”

“This Guide considers the entire range of pharmaceutical engineering activity and identifies key attributes of GEP within it, including how GEP relates to and interfaces with GxP,” said Guide Co-Lead Joerg Block, Ph.D., GMP Compliance Engineer, Bayer AG PH-PS Engineering.

Purchase the ISPE Good Practice Guide: Good Engineering Practice (Second Edition) online either digitally or in a bound copy, at ISPE.org/Publications/Guidance-Documents.

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,000+ Members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory and compliance collaborations in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. Visit ISPE.org for more information.

Share article on social media or email:

Impiger’s PeopleOne solution bags the TrustRadius 2021 TechCares Award


News Image

“Our goal is to build solutions aimed at making life easier – PeopleOne is the solution that ticks all the boxes. This award is testimony to the core values behind the PeopleOne solution.”

Impiger Technologies’  PeopleOne digital workplace engagement solution has been awarded the 2021 Tech Cares Award by TrustRadius, based on TrustRadius community nominations and user reviews. 

TrustRadius has recognized Impiger’s efforts for going above and beyond to support its communities, and stepping up to take an active role in the recovery of communities around the world who were struggling in the aftermath of the 2020 Pandemic.

The final 100 recipients of the award were chosen after considering companies’ volunteering, diversity, equity, and inclusion programs, charitable donations, fundraising, and workplace culture, including model support for in-office and remote employees.

Jude Ramayya, the CEO, Impiger Technologies, states, “Our goal is to build solutions aimed at making life easier – PeopleOne is the solution that ticks all the boxes. This award is testimony to the core values behind the PeopleOne solution.”

The PeopleOne platform is the perfect solution for organizations to deploy for a highly collaborative and efficient workplace. The UI, both for web and mobile apps, is simple and virtually self-explanatory. In addition, with its creative, engaging, and productive features, PeopleOne has elevated employee engagement to new heights where an employee can work at optimal efficiency even in a remote work environment.

About Impiger Technologies

Impiger Technologies is a leading Digital Transformation Solution Provider based out of Dallas, TX, digitally transforming businesses with Digital Solutions in Mobile, Cloud, Web, IoT, AR, RPA, and AI Technologies. We have been in the tech services industry for more than 17 years and have provided services for more than 400 clients across multiple industries, including but not limited to Manufacturing, Logistics, Retail, Healthcare, and Finance. We’ve brought more than 1000 creative, cutting-edge digital solutions to life for our clients across a range of technologies – iOS, Android, React Native, Flutter, AWS, Azure, SharePoint, Drupal, WordPress, and so on. We’re here to help your business achieve today’s goals and tomorrow’s vision.

About TrustRadius

TrustRadius is a reputable business technology review site that doubles as an online community for member companies to provide in-depth reviews of various business softwares and technologies that they have used. Since 2016, the TrustRadius Awards have been the industry standard for unbiased recognition of B2B technology products.

Share article on social media or email:

Eturi’s OurPact App Gives Parents Control Over Their Kids’ Internet Use While a New Investigation Looks Into the Harm of Instagram on Children


Parents can keep their children safe when online with OurPact.

OurPact allows parents to manage their child’s screen.

“We developed OurPact to provide parents with the ability to not only protect their kids, but to keep them focused on what matters most.”

In a surprising and historic announcement, a bipartisan group of 10 state attorneys general have launched an investigation into the harmful effects of Instagram on children and teenagers. More states are sure to follow suit as technology continues to overtake the lives of children across the country. At issue is whether Meta, the social media company formerly known as Facebook, (Nasdaq: FB) violated the consumer protection laws and “put the public at risk.” The investigation comes after leaked internal documents show the company’s own researchers found that the Instagram platform can damage the mental health and body image of young users and can amplify dangerous behaviors such as depression, anxiety and eating disorders.

While the attorneys general are seeking practices and policies from Meta, Facebook and Instagram that promote the health, safety and welfare of kids and teens nationwide, concerned parents can take immediate action to protect their children by utilizing the innovative tools of the OurPact app. This leading parental control app for both iOS and Android devices allows parents to monitor, guard and control their children’s online and internet exposure on mobile devices. It also serves as an all-in-one time management solution enabling parents to limit their child’s online access at their discretion and track a child’s location at any time all from the convenience of their mobile device.

The OurPact cross-platform app (iOS and Android) not only puts parents in control of how much time their kids can spend online, but just as importantly, what type of content and apps they are allowed to utilize. From text messages and app blocking, to website filtering and locator abilities, parents now have a wide-range of online management supervisory tools to keep their children safe from unwanted, unsolicited and intrusive or even harmful content. To date, this ground-breaking technology is used by millions of parents nationwide and is widely recognized as the leading mobile device management tool on the market.

“We developed OurPact to provide parents with the ability to not only protect their kids, but to keep them focused on what matters most: family, outdoor activities, social interaction and scholastic endeavors,” says Amir Moussavian, CEO of Eturi Corp. “We’re proud that millions of families rely on OurPact on a daily basis.” By monitoring and limiting their screen time, parents are not only instilling children with their family’s values and priorities, but they’re helping them develop a healthy relationship with technology instead of letting technology become the driving influence in their lives.

As technology continues to grow, expand and further imbed itself in our culture as well as the lives of our children, parenting has never been more challenging. From social media to gaming to online apps such as TikTok, Snapchat and Instagram to round-the-clock texting, teens and even young children are using digital devices literally anytime and anywhere. As a result, OurPact is the perfect solution for parents who want to protect their kids and keep them safe in the technology driven world we live in. In fact, OurPact not only can remove apps from devices, but it can take screen shots during in-app use to give parents a clear view into the content their kids are engaging with.

Eturi Corp. is the nation’s leading developer of mobile device management programs and technology. The company’s flagship cross-platform app, OurPact, was created to empower parents nationwide with the tools to put them in control of how their kids engage with the online universe. It’s the ultimate tool that gives parents the peace-of-mind they want in today’s fast-paced, technology driven world. For more information on Eturi or the OurPact app, visit eturi.com.

— ### —

Contact:

Bob Shade

Director, Marketing and Corporate Communications

Eturi Corp.

949-922-3148

Bob.shade@eturi.com

12255 El Camino Real

San Diego, Ca. 92130

Share article on social media or email:

Somly adds Chief Clinical Officer: Globally Recognized Sleep Expert


Somly insomnia treatment

Dr. Jack Edinger Chief Clinical Officer

“Dr. Edinger’s decades of expertise leading treatments for insomnia bring a level of offerings patients can’t find anywhere else. We’re incredibly excited about how he will work with us to continue treating our patients and getting them back to quality sleep,” says Dr. Oexman, Somly CEO & Founder.

Somly, the company at the forefront of treatment for insomnia, announces the addition of Dr. Jack Edinger as the organization’s Chief Clinical Officer.

“The addition of Dr. Jack is a great win for Somly,” says Dr. Robert Oexman, Somly Chief Executive Officer and Founder. “Dr. Jack’s decades of expertise leading treatments for insomnia bring a level of offerings patients can’t find anywhere else. We’re incredibly excited about how he will work with us to continue treating our patients and getting them back to quality sleep.”

Dr. Edinger has been studying and treating sleep disorders for nearly 40 years. He has authored more than 150 pieces of research, and has been featured in the Journal of the American Medical Association, Archives of Internal Medicine, JAMA Psychiatry, Sleep, Journal of Clinical Sleep Medicine, Journal of Sleep Research, and many, many others.

In addition to his role with Somly, Dr. Edinger serves as a professor in the department of Medicine at National Jewish Health. His work there focuses largely on insomnia research and treatment.

With Somly, Edinger will continue his focus on causes and mechanisms involved in insomnia, as well as developing and/or improving current insomnia management strategies. His expertise will help Somly’s board-credentialed sleep coaches continue to improve on their already high-level of sleep coaching.

“I’m always excited about the opportunity to help people improve their sleep,” says Edinger. “Doing it with Somly will allow me to help many more people than I might have otherwise.”

About Somly

Somly is an organization focused on helping people through insomnia without the use of medicine or sleep aids. Somly patients work through a six-week CBTI program based on research and clinical practice. Over the course of our program, patients come to understand the science of sleep. The Somly board-credentialed sleep coaches guide patients through the process of changing their thoughts around sleep, teach them how to identify the internal and external factors that rob them of rest, and help them retrain their brains to discover the drive for sleep. The Somly program consists of one-on-one discussions with a sleep coach—no bots or self-guided treatments. The treatment program is based on each individual situation and is customized to fit each patient’s sleep needs.

Share article on social media or email: